Navigation Links
Miracle Cancer Drug in the Pipeline

Cure for cancer has been on the wish-list of many scientists and sufferers the world over. Now, a world of promise awaits the brain–child of an //Australian scientist, whose perseverance on the capacity of a drug to thwart the growth of cancer cells, seems to have paid off.

Professor Chris Parish , who has been working on his ‘baby’ for the past 20 years, may just do himself and the Australian National University proud, as the drug is on the final lap of clinical trials. The drug which will be known by the name of Heparanase, is endowed with the power to delay the growth of cancerous cells.

"The way it works is it interferes with new blood vessels growing into tumors and it also prevents the tumors from spreading by inhibiting an enzyme they need to spread with," Prof Parish said.

The trials that have been undertaken so far have been on liver cancer patients, but this drug could be useful to treat other cancers as well. "It stops the cancers growing any further in about 40 per cent of the patients that have been treated with the drug and we hope that by combining it with other things we can improve on that." Prof Parish said.

The drug is slated to enter the third phase of the clinical trial, which will span a four year timeframe, to be tested on many patients worldwide. The good news is that the drug may also be priced reasonably.
SV
'"/>




Page: 1

Related medicine news :

1. Miracle cure for Alzheimer’s around the corner
2. A Mirror Miracle!
3. ‘Miracle’ HIV Cure Claim Under Scrutin
4. Miracle Cures Do Exist
5. Miracle Baby Boy from a Type 3 osteogenesis imperfecta, Mother
6. Miracle Child Survives Abandonment and Critical Heart Surgery
7. Man Holds Own Skull in Bengal Medical Miracle
8. Miracle Boy Prince Declared Fit by Medical Team
9. "Miracle" Cancer Drug Gleevec Can be Toxic to the Heart
10. Age of Medical Miracles has come upon us
11. Uses for Botulinum Toxin — A Miracle Poison — Continue to Grw
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: